Beta thalassemia
Dernière mise à jour 3 Apr 2025
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Beta thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body.
Sélections vidéo pour Conditions génétiquesBibliothèque vidéo
Description
Beta thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body.
In people with beta thalassemia, low levels of hemoglobin reduce oxygen levels in the body. Affected individuals also have a shortage of red blood cells (anaemia), which can cause pale skin, weakness, fatigue, and more serious complications. People with beta thalassemia are at an increased risk of developing abnormal blood clots.
Beta thalassemia is classified into two types depending on the severity of symptoms: thalassemia major (also known as transfusion-dependent thalassemia or Cooley's anaemia) and thalassemia intermedia (which is a non-transfusion-dependent thalassemia). Of the two types, thalassemia major is more severe.
The signs and symptoms of thalassemia major appear within the first 2 years of life. Children develop life-threatening anaemia. They do not gain weight and grow at the expected rate (failure to thrive) and may develop yellowing of the skin and whites of the eyes (jaundice). Affected individuals may have an enlarged spleen, liver, and heart, and their bones may be misshapen. Puberty is delayed in some adolescents with thalassemia major.
Many people with thalassemia major have such severe symptoms that they need frequent blood transfusions to replenish their red blood cell supply. Over time, an influx of iron-containing hemoglobin from chronic blood transfusions can lead to a buildup of iron in the body, resulting in liver, heart, and hormone problems.
Thalassemia intermedia is milder than thalassemia major. The signs and symptoms of thalassemia intermedia appear in early childhood or later in life. Affected individuals have mild to moderate anaemia and may also have slow growth, bone abnormalities, and an increased risk of developing abnormal blood clots.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Erythroblastic anaemia
Mediterranean anaemia
Thalassemia, beta type
Related patient information and medicines

Patient information leaflet
Thalassémie
Thalassaemia is an inherited condition affecting the blood. For the more severe forms of thalassaemia, modern treatment gives a good outlook, but lifelong monitoring and treatment are needed. What is thalassaemia. Thalassaemia is an inherited (genetic) condition affecting the blood. There are different types of thalassaemia. Depending on which.

Patient information leaflet
Effluvium télogène
Telogen effluvium (hair loss) is a condition where more than normal amounts of cheveux fall out. There is a general 'thinning' of the hair. Many other medications have been linked to telogen effluvium, but some of the most common are beta-blockers; retinoids, including excess vitamin A (often used for skin problems); anticoagulants (often called.

Patient information leaflet
Syndrome de vibration main-bras
Hand-arm vibration syndrome (sometimes abbreviated to HAVS) causes changes in the sensation of the fingers which can lead to permanent numbness of fingers, muscle weakness and, in some cases, bouts of white finger. Avoid medications that can make the circulation to the fingers worse Examples include: Beta-blockers Beta-blockers , which are used.

Patient information leaflet
Hyperlipidémie
Hyperlipidaemia means a high level of cholesterol or triglycerides in votre blood. What causes hyperlipidaemia. Hyperlipidaemia is often found when people are overweight or have an unhealthy diet. Xanthelasma - fatty deposits in the eyelids. Xanthelasma_palpebrarum Bobtheowl2 at the English Wikipedia, CC BY-SA 3.0 , via Wikimedia Commons See the.

Patient information leaflet
Glande thyroïde hyperactive
Smoking can actually make your eye problems worse. Beta-blocker medicines Some people are given a bêta-bloquant médecine Bêta-bloquants (for example, propranolol Propranolol - a beta-blocker , atenolol Atenolol - a beta-blocker ) for a few weeks whilst the level of thyroxine is reduced gradually by one of the above treatments. Beta-blockers can help.

Patient information leaflet
Puis-je prendre Alogliptine et Bisoprolol ensemble ?
It can also slightly increase the risk of your blood sugar dropping too low. Why this happens Bisoprolol est a beta-blocker. These medicines can mask the physical symptoms of low blood sugar, such as a fast heartbeat or tremors. Using other medicines Taking multiple ... Our Medicines Interaction Checker helps you check whether your prescriptions,.
Lectures complémentaires et références
- Beta thalassemia; MedlinePlus, National Library of Medicine.
- Akhavan-Niaki H, Derakhshandeh-Peykar P, Banihashemi A, Mostafazadeh A, Asghari B, Ahmadifard MR, Azizi M, Youssefi A, Elmi MM. A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis. 2011 Jun 15;47(1):29-32. doi: 10.1016/j.bcmd.2011.03.005. Epub 2011 Apr 13.
- Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010 Feb;12(2):61-76. doi: 10.1097/GIM.0b013e3181cd68ed.
- Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11.
- Jarjour RA, Murad H, Moasses F, Al-Achkar W. Molecular update of beta-thalassemia mutations in the Syrian population: identification of rare beta-thalassemia mutations. Hemoglobin. 2014;38(4):272-6. doi: 10.3109/03630269.2014.912661. Epub 2014 May 14.
- Langer AL. Beta-Thalassemia. 2000 Sep 28 [updated 2026 Feb 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1426/
- National Human Genome Research Institute
- Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005 Sep 15;353(11):1135-46. doi: 10.1056/NEJMra050436. No abstract available.
- Thein SL. The molecular basis of beta-thalassemia. Cold Spring Harb Perspect Med. 2013 May 1;3(5):a011700. doi: 10.1101/cshperspect.a011700.
- Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001 Oct;38(4):350-9. doi: 10.1016/s0037-1963(01)90029-0.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

